Epidemiological characteristics of NHL patients and control subjects
| . | NHL . | Controls . | ||||
|---|---|---|---|---|---|---|
| Total . | HBV . | HCV . | Total . | HBV . | HCV . | |
| Patients/subjects | 550 | 21 (3.8%) | 86 (15.6%) | 148 | 2 (1.3%) | 3 (2.02%) |
| Age (y) | ||||||
| Median | 52 | 45 | 58 | 56 | 51 | 63 |
| (range) | (38-67) | (38-64) | (42-67) | (44-72) | (44-58) | (49-72) |
| Sex (m/f) | 271/279 | 11/10 | 35/51 | 78/70 | 2/0 | 2/1 |
| HBeAg/HBeAb | 0/21 | 0/21 | 0/1 | 0/2 | 0/2 | — |
| HBcAb | 108 | 21 | 26 | 13 | 2 | — |
| HBsAg | 21 | 21 | 1 | 2 | 2 | — |
| HBV-DNA+/HBV-DNA−* | — | 0/21 | 0/1 | 0/2 | 0/2 | — |
| HBV-DNA+/HBV-DNA−† | — | 15/0* | 1/0 | — | — | — |
| HCV-Ab/HCV-RNA | 86/86 | 1/1 | 86/86 | 3/3 | 0 | 3/3 |
| ALT* mean (SD) | 35.73 ± 21.3 | 22.27 ± 9.4 | 25.68 ± 12.4 | 33.4 ± 15.7 | 66 ± 16.9 | 62 ± 18.5 |
| ALT† mean (SD) | 31.67 ± 28.5 | 1051.28 ± 898.5‡ | 32.8 ± 28.7 | — | — | — |
| . | NHL . | Controls . | ||||
|---|---|---|---|---|---|---|
| Total . | HBV . | HCV . | Total . | HBV . | HCV . | |
| Patients/subjects | 550 | 21 (3.8%) | 86 (15.6%) | 148 | 2 (1.3%) | 3 (2.02%) |
| Age (y) | ||||||
| Median | 52 | 45 | 58 | 56 | 51 | 63 |
| (range) | (38-67) | (38-64) | (42-67) | (44-72) | (44-58) | (49-72) |
| Sex (m/f) | 271/279 | 11/10 | 35/51 | 78/70 | 2/0 | 2/1 |
| HBeAg/HBeAb | 0/21 | 0/21 | 0/1 | 0/2 | 0/2 | — |
| HBcAb | 108 | 21 | 26 | 13 | 2 | — |
| HBsAg | 21 | 21 | 1 | 2 | 2 | — |
| HBV-DNA+/HBV-DNA−* | — | 0/21 | 0/1 | 0/2 | 0/2 | — |
| HBV-DNA+/HBV-DNA−† | — | 15/0* | 1/0 | — | — | — |
| HCV-Ab/HCV-RNA | 86/86 | 1/1 | 86/86 | 3/3 | 0 | 3/3 |
| ALT* mean (SD) | 35.73 ± 21.3 | 22.27 ± 9.4 | 25.68 ± 12.4 | 33.4 ± 15.7 | 66 ± 16.9 | 62 ± 18.5 |
| ALT† mean (SD) | 31.67 ± 28.5 | 1051.28 ± 898.5‡ | 32.8 ± 28.7 | — | — | — |